. Author manuscript; available in PMC: 2012 Nov 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2011 Apr 29;17(11):1662–1672. doi: 10.1016/j.bbmt.2011.04.008

Table 1.

Demographic status of the patient population

Study cohort n = 134	median (range ) or N (Percent)
Recipient Age at Transplant	42.1 (18.8., 63.6)

Donor Age at Transplant	42.1 (18.0, 71.4)

Donor Type
Sibling Donor	87 (65%)
Unrelated Donor	47 (35%)

Material Transplanted
Bone Marrow Stem Cells	24 (18%)
Peripheral Blood Stem Cells	110 (82%)

Diagnosis
Lymphoid	51 (38%)
Myeloid	77 (57%)
Other	6 (5%)

Disease Status at Transplant
1^st Complete Remission/Chronic Phase	57 (43%)
Later CR/Later CP	16 (12%)
Relapse	22 (16%)
Induction Failure	22 (16%)
MDS, AA, MM, MPD	17 (13%)

Conditioning
Fludarabine/Melphalan	45 (34%)
Myeloablative	88 (66%)

CMV serology
missing	1
D−/R+	33 (25%)
D+/R−	14 (10%)
D+/R+	86 (65%)

Acute GVHD Grade
0-I	53 (40%)
II-IV	81 (60%)

Chronic GVHD Grade
None	21 (16%)
Limited	15 (11%)
Extensive	98 (73%)

AA: aplastic anemia; MM; multiple myeloma